Search results
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 2 days agoMerck reported improvement in cancer patients receiving its Keytruda regimen. Enrolling 698...
Moderna plants new solid tumor trials for cancer vaccine, weeds PD-1 work after review
FierceBiotech· 2 days agoModerna detailed plans for its individual neoantigen cancer vaccine in a first-quarter earnings...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 2 days agoMeanwhile, Moderna is expanding its efforts in cancer treatment. The company is partnered with Merck...
Amgen Inc. (NASDAQ:AMGN) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 21 hours agoAmgen Inc. (NASDAQ:AMGN) Q1 2024 Earnings Call Transcript May 2, 2024 Amgen Inc. beats earnings...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 5 days ago- BeyondSpring Dosed First Patient of Two Phase 2 Investigator-Initiated Trials (IIT) in Plinabulin and Keytruda Combination Studies - SITC 2023 Presentation of the Phase ...
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050
FOX 59 Indianapolis· 3 days agoWhile five-year cancer survival rates are on an upward trend, the biotech sector is racing to meet...
Merck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoMerck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript April 25, 2024 Merck & Co., Inc. beats...
What is the Outlook for a Mesothelioma Diagnosis?
Daily Sundial· 2 days agoOver the past 15 or 20 years, a rare form of cancer known as mesothelioma has become increasingly common – affecting as many as 3,000 Americans each year. What is Mesothelioma ...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 2 days agoBMS strengthened its neuroscience portfolio with the acquisition of Karuna Therapeutics, and its lead asset, KarXT (trospium chloride + xanomeline), a...
Personalized Melanoma Vaccine Could Be a 'Game Changer' by Teaching the Body to Fight Cancer Cells
Smithsonian Magazine· 5 days agoA global trial has begun for the world’s first personalized vaccine for melanoma—the deadliest form of skin cancer, which affects about 132,000 people per year. If successful ...
